annual current liabilities:
$173.76M-$51.65M(-22.91%)Summary
- As of today (September 17, 2025), AMPH annual total current liabilities is $173.76 million, with the most recent change of -$51.65 million (-22.91%) on December 31, 2024.
- During the last 3 years, AMPH annual current liabilities has risen by +$69.95 million (+67.38%).
- AMPH annual current liabilities is now -22.91% below its all-time high of $225.41 million, reached on December 31, 2023.
Performance
AMPH Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$176.41M-$22.64M(-11.38%)Summary
- As of today (September 17, 2025), AMPH quarterly total current liabilities is $176.41 million, with the most recent change of -$22.64 million (-11.38%) on June 30, 2025.
- Over the past year, AMPH quarterly current liabilities has increased by +$39.44 million (+28.79%).
- AMPH quarterly current liabilities is now -31.62% below its all-time high of $257.96 million, reached on September 30, 2023.
Performance
AMPH quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AMPH Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | +28.8% |
| 3 y3 years | +67.4% | +70.2% |
| 5 y5 years | +93.0% | +89.1% |
AMPH Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.9% | +83.2% | -31.6% | +86.0% |
| 5 y | 5-year | -22.9% | +93.0% | -31.6% | +89.1% |
| alltime | all time | -22.9% | >+9999.0% | -31.6% | +213.4% |
AMPH Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $176.41M(-11.4%) |
| Mar 2025 | - | $199.05M(+14.6%) |
| Dec 2024 | $173.76M(-22.9%) | $173.76M(+9.3%) |
| Sep 2024 | - | $159.01M(+16.1%) |
| Jun 2024 | - | $136.97M(-46.3%) |
| Mar 2024 | - | $255.17M(+13.2%) |
| Dec 2023 | $225.41M(+137.6%) | $225.41M(-12.6%) |
| Sep 2023 | - | $257.96M(+2.7%) |
| Jun 2023 | - | $251.28M(+137.9%) |
| Mar 2023 | - | $105.64M(+11.4%) |
| Dec 2022 | $94.86M(-8.6%) | $94.86M(-7.2%) |
| Sep 2022 | - | $102.19M(-1.4%) |
| Jun 2022 | - | $103.63M(-9.4%) |
| Mar 2022 | - | $114.36M(+10.2%) |
| Dec 2021 | $103.81M(-7.5%) | $103.81M(+5.9%) |
| Sep 2021 | - | $97.99M(-21.3%) |
| Jun 2021 | - | $124.55M(-2.0%) |
| Mar 2021 | - | $127.10M(+13.3%) |
| Dec 2020 | $112.20M(+24.7%) | $112.20M(+16.0%) |
| Sep 2020 | - | $96.72M(+3.7%) |
| Jun 2020 | - | $93.29M(+11.9%) |
| Mar 2020 | - | $83.37M(-7.4%) |
| Dec 2019 | $90.01M | $90.01M(+3.9%) |
| Sep 2019 | - | $86.60M(-14.3%) |
| Jun 2019 | - | $101.00M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $111.96M(+4.8%) |
| Dec 2018 | $106.83M(+59.0%) | $106.83M(+10.6%) |
| Sep 2018 | - | $96.62M(+10.3%) |
| Jun 2018 | - | $87.59M(+20.7%) |
| Mar 2018 | - | $72.54M(+8.0%) |
| Dec 2017 | $67.19M(+10.8%) | $67.19M(+17.1%) |
| Sep 2017 | - | $57.40M(-9.9%) |
| Jun 2017 | - | $63.70M(-12.6%) |
| Mar 2017 | - | $72.86M(+20.2%) |
| Dec 2016 | $60.62M(+1.1%) | $60.62M(-0.4%) |
| Sep 2016 | - | $60.84M(-7.4%) |
| Jun 2016 | - | $65.67M(+1.1%) |
| Mar 2016 | - | $64.92M(+8.3%) |
| Dec 2015 | $59.95M(-4.2%) | $59.95M(-15.1%) |
| Sep 2015 | - | $70.65M(+1.8%) |
| Jun 2015 | - | $69.40M(-3.7%) |
| Mar 2015 | - | $72.09M(+15.2%) |
| Dec 2014 | $62.59M(-4.3%) | $62.59M(-0.8%) |
| Sep 2014 | - | $63.08M(+12.1%) |
| Jun 2014 | - | $56.28M(-22.7%) |
| Mar 2014 | - | $72.81M(+11.3%) |
| Dec 2013 | $65.40M(+8.9%) | $65.40M(-16.6%) |
| Sep 2013 | - | $78.45M(+30.6%) |
| Dec 2012 | $60.08M(>+9900.0%) | - |
| Dec 2012 | - | $60.08M |
| Dec 2011 | $0.00 | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual total current liabilities?
The current annual current liabilities of AMPH is $173.76M
What is the all time high annual current liabilities for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual total current liabilities is $225.41M
What is Amphastar Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, AMPH annual total current liabilities has changed by -$51.65M (-22.91%)
What is Amphastar Pharmaceuticals, Inc. quarterly total current liabilities?
The current quarterly current liabilities of AMPH is $176.41M
What is the all time high quarterly current liabilities for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly total current liabilities is $257.96M
What is Amphastar Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, AMPH quarterly total current liabilities has changed by +$39.44M (+28.79%)